News

Tonix Pharmaceuticals Engages at Upcoming Global Vaccine Event

Tonix Pharmaceuticals Engages at Upcoming Global Vaccine Event

Tonix Pharmaceuticals' Exciting Participation in Global Vaccine Congress

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a dynamic biotechnology company, is gearing up to make a significant impact at the World Vaccine Congress in Europe. With a focus on enhancing vaccine effectiveness, Tonix is excited to announce that Dr. Sina Bavari, Ph.D., and Dr. Zeil Rosenberg, M.D., will be representing the company at this prestigious event scheduled for mid-October.

Conference Details You Should Know

The World Vaccine Congress Europe 2025 will take place over three days, providing a platform for leading voices in the vaccine and immunology sectors. Dr. Bavari, a recognized leader in infectious disease research, will present vital information on the safety and efficacy of Tonix’s groundbreaking TNX-801 Mpox vaccine.

Presentation Highlights

Dr. Bavari's presentation is titled "Safety, Durability and Protection of a Single-Dose TNX-801 Mpox Vaccine" and is set for October 15, 2025, at 2:15 p.m. CEST. This session aims to share crucial data and insights that could pave the way for advancements in vaccine technology.

Panel Discussion Insights

Alongside Dr. Bavari, Dr. Zeil Rosenberg will moderate a fascinating panel discussion focused on the question: "Can We Enhance Vaccine Effectiveness? Mpox (Monkeypox) as a Model." This panel will take place on October 14, offering a collaborative discussion with experts from various institutions, including the Kenya Medical Research Institute.

Tonix Pharmaceuticals: A Leader in Biotech Innovation

Tonix Pharmaceuticals continues to stand at the forefront of biopharmaceutical innovation with its robust pipeline of development candidates. One of the company’s notable achievements includes gaining FDA approval for Tonmya™, a unique non-opioid treatment for fibromyalgia. This comes as a major breakthrough in a field lacking new treatments for over a decade.

The company is not only innovating in pain management but is also actively pursuing solutions across various health challenges such as CNS disorders, rare diseases, and infectious diseases. With a portfolio that includes the promising TNX-801 vaccine for mpox and smallpox, and a monoclonal antibody being developed for Lyme Disease, Tonix exemplifies a commitment to public health and safety.

Future Directions and Innovations

Tonix is paving the way for future innovations, particularly in the areas of immunology and infectious disease therapies. The company's contract with the U.S. Department of Defense underscores its dedication to improving the medical readiness of military personnel in the face of biological threats. Their ongoing projects and research aim to develop antiviral agents, such as TNX-4200, targeting infectious diseases.

Get Involved and Stay Informed

For those interested in learning more about the presentations and discussions at the World Vaccine Congress Europe 2025, information will be available on the Tonix website under the Presentations tab following the conference. This event is an excellent opportunity for healthcare professionals, researchers, and stakeholders to connect and explore the latest advancements in vaccine technologies and public health.

Stay Connected with Tonix Pharmaceuticals

Tonix invites everyone to stay informed about their innovative initiatives by visiting their official website and following upcoming updates regarding their research endeavors and public health commitments. Whether you're an investor, a healthcare provider, or just someone interested in biopharmaceutical innovations, there will be plenty to learn from Tonix in the coming months.

Frequently Asked Questions

What is Tonix Pharmaceuticals known for?

Tonix Pharmaceuticals is known for its innovative approach in developing treatments for various medical conditions, notably gaining FDA approval for a non-opioid pain treatment for fibromyalgia.

When will Tonix participate in the World Vaccine Congress?

Tonix will participate in the World Vaccine Congress Europe 2025 on October 14-16, where key presentations and discussions will be held.

Who will be presenting for Tonix Pharmaceuticals?

Dr. Sina Bavari and Dr. Zeil Rosenberg will be presenting and moderating discussions at the congress.

What is TNX-801?

TNX-801 is a vaccine candidate developed by Tonix for the prevention of mpox and smallpox, showcasing promising efficacy in clinical settings.

How can I find out more about Tonix's research and development?

You can follow Tonix Pharmaceuticals on their official website to stay updated on their research, products, and company news.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Brazilian Jiu-Jitsu's Ground Game: Real-World Self-Defense

Updated Category News Views 88

From Mat to Reality: Brazilian Jiu-Jitsu's Claim to Fame It ain't all high kicks and flashy moves when it comes to self-defense, folks. Enter Brazilian Jiu-Jitsu (BJJ)—an art that's not just about show but about practical, gritty reality. Ever been curious why this discipline is hailed for self-defense? Wayne Marble, a seasoned martial arts expert, dishes out the why's...

Continue Reading
Doppel's Strategic Expansion: Adding PropRise Innovators

Updated Category News Views 62

Doppel Boosts Its Team with PropRise Founders The market doesn’t lie: when a company's on a roll, you watch it closely. Doppel's latest move is a serious signal. They've snagged PropRise, a sprightly Y Combinator graduate, and landed its founders, Jean-Michael Diei and Matthew Krager, right into their engineering fold. These guys aren't greenhorns—cutting their teeth...

Continue Reading
Virginia Home Projects: Navigating 2026 Material Costs

Updated Category News Views 63

Penny-Pinching with Pricey Planks: Lumber's Wild Ride Every single time you pick up a hammer, it's like gambling on the money pit that is lumber pricing. These costs are so all over the board in 2026, they make whipping your checkbook out feel like a game of roulette. Folks over in Culpeper and the greater Virginia space are no strangers to this chaotic dance. Travis...

Continue Reading
Fluence Energy Lawsuit: Investors Face Key Deadline

Updated Category News Views 35

Fluence Energy Under Fire Fluence Energy, Inc., ain't having the best of times, folks. If you've been keeping an eye on the stock ticker NASDAQ:FLNC, you probably felt the shiver when the news of a securities fraud class action lawsuit hit the wire. This ain't about some minor slip-up. These allegations are rocking the boat hard. What's at Stake for Investors? Here's the...

Continue Reading
Adient Boosts Buyback, Shields Valuable Tax Assets

Updated Category News Views 47

Adient's Aggressive Buyback and Tax Strategy Well, it looks like Adient's not just sitting on its hands. They've not only opened up the cash taps with a $400 million increase in their share repurchase authorization but also shored up their defenses with a Tax Benefits Preservation Plan. You know, when a company dishes out that kind of cash, it tells you they see some...

Continue Reading
ACLS Expands Fellowship Program for Emerging Scholars

Updated Category News Views 62

Expanding Opportunities in Religious Scholarship Here's something you don't see every day: a program that's actually trying to bridge academia and the practical world. The American Council of Learned Societies (ACLS) is rolling out its second wave of their Graduate Internships on the Spiritual Infrastructure of the Future for 2027, backed by the Templeton Religion Trust....

Continue Reading
Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Updated Category News Views 93

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Continue Reading
Lemon Grove Bans Bird Sales to Combat Cruelty

Updated Category News Views 95

A Bird's Eye View on Lemon Grove's Bold Stand The folks in Lemon Grove, California, just sent out a loud and clear message: put an end to the inhumane sale of birds in pet stores. With 65% of voters backing Measure E, they've decided that birds fly best when they aren't part of a retail circus. Under this new rule, stores can only put birds up for adoption if they're...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 98

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading
Kate Spade Unveils Festive 2026 Holiday Campaign

Updated Category News Views 49

Kate Spade's Bold Holiday Blitz Ah, holiday campaigns. They’re like the department store windows of the digital age—bursting with color, life, and a hint of commercial frenzy. And Kate Spade New York’s 2026 holiday campaign? Well, it’s certainly making waves. Featuring a crew of high-profile creators, this campaign unfolds like a lavish NYC holiday party—styled...

Continue Reading

Top 5 Most Recently Viewed Articles

Lithium Africa Resources Corp. Expands Board with New Leaders

Updated Category News Views 47

Lithium Africa Resources Corp. Announces Board Changes Lithium Africa Resources Corp. has recently announced notable expansions to its Board of Directors. These strategic enhancements come as the company continues to consolidate its position within the hard rock lithium segment, particularly in various promising regions. New Additions to the Board The Company is excited...

Continue Reading
Transforming Business Interactions with AI-Driven Solutions

Updated Category News Views 128

AI Enhancements in Enterprise Collaboration As artificial intelligence technology evolves, its role in modern business has become more prominent, especially in enhancing collaboration and communication within enterprises. Organizations are increasingly relying on AI capabilities to improve teamwork and customer engagement. The Impact of Conversational AI According to...

Continue Reading
Insights into US Financial 15 Split Corp's Mid-Year Results

Updated Category News Views 121

Financial Overview of US Financial 15 Split Corp The recent financial results released by US Financial 15 Split Corp highlight their performance for the initial half of the fiscal year. Investors and stakeholders are keenly analyzing these results to gauge the company's financial health and operational efficiency. Performance Metrics and Analysis The semi-annual financial...

Continue Reading
Two Promising Utilities Stocks to Watch This Month

Updated Category News Views 78

Investing in Oversold Utilities Stocks The utilities sector has seen some fascinating movements lately, particularly among stocks that may be undervalued and present a unique opportunity for savvy investors. When companies in this sector are trading at lower prices, it can be enticing to consider adding them to your portfolio. An excellent method to gauge potential is...

Continue Reading
Ford Stock's Struggles Highlight Broader Industry Challenges

Updated Category News Views 319

Ford Motor Company's Recent Stock Performance This year has been quite turbulent for the automotive industry, and Ford Motor Company (NYSE: F) recently hit a 52-week low with its stock price falling to $3.33. This marks a dramatic drop, showing a year-long decline of -56.58%. Ford's struggles are not just a reflection of the broader market, but also stem from specific...

Continue Reading